86885-57-6

Basic information

• Product Name: trans Methyl 6-oxabicyclo[3.1.0]hexane-3-carboxylate
• Synonyms: trans Methyl 6-oxabicyclo[3.1.0]hexane-3-carboxylate;methyl (1R,3S,5S)-rel-6-oxabicyclo[3.1.0]hexane-3-carboxylate
• CAS NO: 86885-57-6
• Molecular Formula: C₇H₁₀O₃
• Molecular Weight: 142.1525
• Mol File: 86885-57-6.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• CAS DataBase Reference: trans Methyl 6-oxabicyclo[3.1.0]hexane-3-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: trans Methyl 6-oxabicyclo[3.1.0]hexane-3-carboxylate(86885-57-6)
• EPA Substance Registry System: trans Methyl 6-oxabicyclo[3.1.0]hexane-3-carboxylate(86885-57-6)

Safety Data

• Hazardous Substances Data: 86885-57-6(Hazardous Substances Data)

Usage

General Description

Trans Methyl 6-oxabicyclo[3.1.0]hexane-3-carboxylate is a chemical compound with the molecular formula C8H10O3. It is a bicyclic compound that contains a six-membered oxygen-containing ring. trans Methyl 6-oxabicyclo[3.1.0]hexane-3-carboxylate is commonly used in organic synthesis and pharmaceutical applications. It is known for its unique structure and functional groups, which make it an interesting target for chemical research and development. The trans configuration of the compound refers to the arrangement of the substituent groups on the carbon-carbon double bond, which affects its reactivity and properties. Overall, trans Methyl 6-oxabicyclo[3.1.0]hexane-3-carboxylate is a versatile compound with potential applications in various chemical and pharmaceutical industries.

Upstream product

• 58101-60-3 methyl cyclopent-3-ene-1-carboxylate 

Downstream Products

• 1214921-49-9 (1S,3S,4S)-methyl 3-fluoro-4-hydroxycyclopentanecarboxylate 
• 366006-09-9 methyl (3R,4R)-3,4-dihydroxycyclopentanecarboxylate 
• 174292-58-1 methyl (1S,3S)-3-hydroxycyclopentanecarboxylate 
• 136522-33-3 (1S,4R)-4-[2-amino-6-chloro-9H-purin-9-yl]-2-cyclopentene-1-methanol 
• 852364-14-8 Toluene-4-sulfonic acid (1S,3S,5R)-1-(6-oxa-bicyclo[3.1.0]hex-3-yl)methyl ester 

Relevant articles and documents

3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR

The present invention is directed to pyrazol-4-yl-pyridine compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.

NITROOXY CYCLOALKANE DERIVATIVES

A compound having the structure wherein Y is selected from the group consisting of –C(O)OR2, -C(O)NHR8, -C(CH2)1-2OR3, OH, and or a pharmaceutically acceptable salt thereof, and methods of using the compounds for treating hypertension.

Carbocyclic 3′-deoxyadenosine-based highly potent bisubstrate-analog inhibitor of basophilic protein kinases

Carbocyclic analogs of 3′-deoxyadenosine were synthesized as racemates and the resulting stereoisomers were separated by chromatography on a chiral column. The conjugation of obtained compounds with hexa-(d-arginine) via 6-aminohexanoic acid linker led to a highly potent inhibitor of several basophilic protein kinases with some selectivity towards cAMP-dependent protein kinase.